search
Back to results

¿Can mySugr App Improve Knowledge and Self-management of People With Type 1 Diabetes Mellitus?

Primary Purpose

Diabetes Mellitus, Type 1

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
mySugr app
Standard care
Sponsored by
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Diabetes Mellitus, Type 1 focused on measuring Diabetes Mellitus, Type 1, Mobile Applications, Telemedicine

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients over 18 years of age
  • People with type 1 diabetes (> 1 year diagnosis)
  • Treatment with insulin in basal-bolus regimen
  • Glucometer that connects automatically with the app
  • HbA1c 7-9%
  • Understanding of carbohydrate counting and concepts of ratio and factor of sensitivity
  • Have a smartphone or tablet

Exclusion Criteria:

  • Use at the time of randomization of another app for diabetes management
  • Use of continuous monitoring or flash glucose systems
  • Pregnancy
  • Any other disease or condition that may interfere with the completion of the protocol or completion of the study

Sites / Locations

  • Hospital de la Santa Creu i Sant Pau

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Standard care

mySugr app

Arm Description

Usual follow-up of diabetes type 1 with face-to-face visits

Telemedical assistance with mySugr app

Outcomes

Primary Outcome Measures

Empowerment
Change from baseline score in the Diabetes Empowerment Scale-Short Form Spanish version (DES-SF-S) (8, worse to 40, better) at 12 months

Secondary Outcome Measures

Adherence to glycemic monitoring
Change from baseline frequency of glycemic monitoring (number of capillary blood glucose tests per day) at each follow-up visit
Adherence to recommendations
Percentage of recommendations given by the medical team followed
Adherence to visits
Percentage of face-to-face visits and telematic visits attended
Adherence to the app
Percentage of patients who continue using the app after the end of the study
Daily management of diabetes
Change from baseline score in the questionnaire that evaluates the number of tasks performed in relation to diabetes (ad hoc) at 12 months
Quality of life related to diabetes
Change from baseline score in the Spanish version of the Diabetes Quality Of Life questionnaire (EsDQOL) (satisfaction: 75, worse, to 15, better; impact: 85, worse, to 17, better; social and vocational concern: 45, worse, to 7, better; concern related to diabetes: 20, worse, to 4, better) at 12 months
Self-efficacy
Change from baseline score in the Diabetes Distress Scale Spanish version (DSS-S) (102, worse, to 17, better) at 12 months
Glycemic control
Change from baseline mean blood glucose (mg/dl), standard deviation, low and high blood glucose index at each follow-up visit
Glycemic control
Change from baseline HbA1c DCA (%) at 6 and 12 months
Satisfaction with the app
Score in the satisfaction questionnaire in relation to the use of the platform (ad hoc)

Full Information

First Posted
January 22, 2019
Last Updated
September 18, 2021
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Collaborators
Roche Diagnostics
search

1. Study Identification

Unique Protocol Identification Number
NCT03819335
Brief Title
¿Can mySugr App Improve Knowledge and Self-management of People With Type 1 Diabetes Mellitus?
Official Title
¿Puede Una aplicación móvil Mejorar el Conocimiento y la autogestión de Las Personas Con Diabetes Tipo 1? Evaluación clínica de la App mySugr
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Completed
Study Start Date
April 9, 2019 (Actual)
Primary Completion Date
February 26, 2021 (Actual)
Study Completion Date
April 13, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Collaborators
Roche Diagnostics

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This project is based on the contribution that an app can offer for improving knowledge and self-management of people with type 1 diabetes. The main objective of this study is to assess mySugr app as a tool for empowering people with type 1 diabetes. The study population are type 1 diabetes people, aged more than 18 years old and with more than one year from diagnosis. They will be randomised to standard care or use of mySugr app and will be followed-up during 48 weeks. Control group will attend 5 face-to-face visits (baseline, 3, 6, 9 and 12 months) with the possibility of telephone contact and hospital assistance if necessary. Intervention group will attend 3 face-to-face visits (baseline, 6 and 12 months) and 2 telematic visits (at 3 and 9 months) and will also have the possibility of telephone contact and hospital assistance if necessary.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 1
Keywords
Diabetes Mellitus, Type 1, Mobile Applications, Telemedicine

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
28 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard care
Arm Type
Active Comparator
Arm Description
Usual follow-up of diabetes type 1 with face-to-face visits
Arm Title
mySugr app
Arm Type
Experimental
Arm Description
Telemedical assistance with mySugr app
Intervention Type
Device
Intervention Name(s)
mySugr app
Intervention Description
mySugr is a mobile medical app for diabetes management. It has been developed by Roche Diabetes Care and it has two versions, free and Pro. It allows to carry out the diary of diabetes, including the collection and analysis of data on glycaemia, food, physical activity or insulin dose. In addition, it is compatible with continuous glucose measurement systems. It has the possibility to add functionalities such as estimation of HbA1c levels, more detailed data analysis or integration with Google Fit type motion sensors, as well as a bolus calculator, reminders for measuring blood glucose or photo gallery in the Pro version, which is the one that will be provided to the patients for the study.
Intervention Type
Other
Intervention Name(s)
Standard care
Intervention Description
Face-to-face visits
Primary Outcome Measure Information:
Title
Empowerment
Description
Change from baseline score in the Diabetes Empowerment Scale-Short Form Spanish version (DES-SF-S) (8, worse to 40, better) at 12 months
Time Frame
Baseline visit and month 12
Secondary Outcome Measure Information:
Title
Adherence to glycemic monitoring
Description
Change from baseline frequency of glycemic monitoring (number of capillary blood glucose tests per day) at each follow-up visit
Time Frame
Baseline visit and month 3, 6, 9 and 12
Title
Adherence to recommendations
Description
Percentage of recommendations given by the medical team followed
Time Frame
Each follow-up visit (month 3, 6, 9 and 12)
Title
Adherence to visits
Description
Percentage of face-to-face visits and telematic visits attended
Time Frame
Each follow-up visit (month 3, 6, 9 and 12)
Title
Adherence to the app
Description
Percentage of patients who continue using the app after the end of the study
Time Frame
End of the study (month 12) and 3 months after
Title
Daily management of diabetes
Description
Change from baseline score in the questionnaire that evaluates the number of tasks performed in relation to diabetes (ad hoc) at 12 months
Time Frame
Baseline visit and month 12
Title
Quality of life related to diabetes
Description
Change from baseline score in the Spanish version of the Diabetes Quality Of Life questionnaire (EsDQOL) (satisfaction: 75, worse, to 15, better; impact: 85, worse, to 17, better; social and vocational concern: 45, worse, to 7, better; concern related to diabetes: 20, worse, to 4, better) at 12 months
Time Frame
Baseline visit and month 12
Title
Self-efficacy
Description
Change from baseline score in the Diabetes Distress Scale Spanish version (DSS-S) (102, worse, to 17, better) at 12 months
Time Frame
Baseline visit and month 12
Title
Glycemic control
Description
Change from baseline mean blood glucose (mg/dl), standard deviation, low and high blood glucose index at each follow-up visit
Time Frame
Baseline visit and month 3, 6, 9 and 12
Title
Glycemic control
Description
Change from baseline HbA1c DCA (%) at 6 and 12 months
Time Frame
Baseline visit and month 6 and 12
Title
Satisfaction with the app
Description
Score in the satisfaction questionnaire in relation to the use of the platform (ad hoc)
Time Frame
End of the study (month 12)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients over 18 years of age People with type 1 diabetes (> 1 year diagnosis) Treatment with insulin in basal-bolus regimen Glucometer that connects automatically with the app HbA1c 7-9% Understanding of carbohydrate counting and concepts of ratio and factor of sensitivity Have a smartphone or tablet Exclusion Criteria: Use at the time of randomization of another app for diabetes management Use of continuous monitoring or flash glucose systems Pregnancy Any other disease or condition that may interfere with the completion of the protocol or completion of the study
Facility Information:
Facility Name
Hospital de la Santa Creu i Sant Pau
City
Barcelona
ZIP/Postal Code
08025
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

¿Can mySugr App Improve Knowledge and Self-management of People With Type 1 Diabetes Mellitus?

We'll reach out to this number within 24 hrs